Processing Peripheral Blood Mononuclear Cells (PBMC) for Clinical Trials

By Cerba Research

PBMC-based analytical tests are crucial to accelerate the development of new vaccines, drug discovery, diagnostic development, Precision Medicine Research (eg. CAR-T cell therapy, gene therapy, etc), and toxicology applications. To this end, the supply of high-quality PBMC is an essential first step in the process.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.